BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37118834)

  • 21. Effect of comprehensive geriatric assessment for frail elderly patients operated for colorectal cancer-the colorectal cancer frailty study: study protocol for a randomized, controlled, multicentre trial.
    Normann M; Ekerstad N; Angenete E; Prytz M
    Trials; 2022 Nov; 23(1):948. PubMed ID: 36397083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Potentially Inappropriate Medications and Frailty in the Early Old Age: A Longitudinal Study in the GAZEL Cohort.
    Martinot P; Landré B; Zins M; Goldberg M; Ankri J; Herr M
    J Am Med Dir Assoc; 2018 Nov; 19(11):967-973.e3. PubMed ID: 30172683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polypharmacy status as an indicator of mortality in an elderly population.
    Jyrkkä J; Enlund H; Korhonen MJ; Sulkava R; Hartikainen S
    Drugs Aging; 2009; 26(12):1039-48. PubMed ID: 19929031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care.
    Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A;
    Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug storage, polypharmacy and frailty syndrome in older people: an observational study.
    Tabué-Téguo M; Villeneuve R; Helene-Pelage J; Cesari M; Chovino J; Boire A; Dramé M; Simo-Tabué N; Boucaud-Maitre D
    Pan Afr Med J; 2023; 45():29. PubMed ID: 37521760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management and Outcome of Colorectal Cancer Liver Metastases in Elderly Patients: A Population-Based Study.
    Booth CM; Nanji S; Wei X; Mackillop WJ
    JAMA Oncol; 2015 Nov; 1(8):1111-9. PubMed ID: 26355283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
    Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
    J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy.
    Slabaugh SL; Maio V; Templin M; Abouzaid S
    Drugs Aging; 2010 Dec; 27(12):1019-28. PubMed ID: 21087071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentially inappropriate medication use and the hospitalization rate among Thai elderly patients: a retrospective cohort study.
    Varavithya V; Tirapat C; Rojpibulstit P; Poovichayasumlit P; Prasert V; Vatcharavongvan P
    Eur J Clin Pharmacol; 2022 May; 78(5):847-855. PubMed ID: 35091789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of potentially inappropriate medications, polypharmacy and anticholinergic burden with readmission and emergency room revisit after discharge: A hospital-based retrospective cohort study.
    Liang CK; Chou MY; Hsu YH; Wang YC; Liao MC; Chen MT; Hsiao PY; Chen LK; Lin YT
    Br J Clin Pharmacol; 2023 Jan; 89(1):187-200. PubMed ID: 35821614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of polypharmacy on healthcare services utilization in older adults with comorbidities: a retrospective cohort study.
    Doumat G; Daher D; Itani M; Abdouni L; El Asmar K; Assaf G
    BMC Prim Care; 2023 May; 24(1):120. PubMed ID: 37237338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frailty Status and Polypharmacy Predict All-Cause Mortality in Community Dwelling Older Adults in Europe.
    Midão L; Brochado P; Almada M; Duarte M; Paúl C; Costa E
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33808273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Factors for Polypharmacy in Elderly Patients With Cancer Pain.
    Morio K; Maeda I; Yokota I; Niki K; Murata T; Matsumura Y; Uejima E
    Am J Hosp Palliat Care; 2019 Jul; 36(7):598-602. PubMed ID: 30630338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population.
    Herr M; Sirven N; Grondin H; Pichetti S; Sermet C
    Eur J Clin Pharmacol; 2017 Sep; 73(9):1165-1172. PubMed ID: 28601963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polypharmacy and patterns of prescription medication use among cancer survivors.
    Murphy CC; Fullington HM; Alvarez CA; Betts AC; Lee SJC; Haggstrom DA; Halm EA
    Cancer; 2018 Jul; 124(13):2850-2857. PubMed ID: 29645083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple medication use in older patients in post-acute transitional care: a prospective cohort study.
    Runganga M; Peel NM; Hubbard RE
    Clin Interv Aging; 2014; 9():1453-62. PubMed ID: 25214773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of cancer-related fatigue with all-cause mortality of colorectal and endometrial cancer survivors: Results from the population-based PROFILES registry.
    Adam S; van de Poll-Franse LV; Mols F; Ezendam NPM; de Hingh IHJT; Arndt V; Thong MSY
    Cancer Med; 2019 Jun; 8(6):3227-3236. PubMed ID: 31012272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies).
    Fialová D; Laffon B; Marinković V; Tasić L; Doro P; Sόos G; Mota J; Dogan S; Brkić J; Teixeira JP; Valdiglesias V; Costa S;
    Eur J Clin Pharmacol; 2019 Apr; 75(4):451-466. PubMed ID: 30610276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.